tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Junshi Biosciences’ 5%+ Shareholder Plans Stake Reduction of Up to 2% via Block Trades
PremiumCompany AnnouncementsJunshi Biosciences’ 5%+ Shareholder Plans Stake Reduction of Up to 2% via Block Trades
1M ago
Shanghai Junshi Biosciences Receives FDA Approval for Cancer Drug JS212
Premium
Company Announcements
Shanghai Junshi Biosciences Receives FDA Approval for Cancer Drug JS212
2M ago
Shanghai Junshi Biosciences Chairman Increases Shareholding to Boost Market Position
Premium
Company Announcements
Shanghai Junshi Biosciences Chairman Increases Shareholding to Boost Market Position
2M ago
Shanghai Junshi Biosciences Announces Shareholder Equity Adjustment
PremiumCompany AnnouncementsShanghai Junshi Biosciences Announces Shareholder Equity Adjustment
2M ago
Shanghai Junshi Biosciences Implements New Cash Management Strategy
Premium
Company Announcements
Shanghai Junshi Biosciences Implements New Cash Management Strategy
2M ago
Shanghai Junshi Biosciences’ JS001sc Achieves Key Milestone in NSCLC Treatment
Premium
Company Announcements
Shanghai Junshi Biosciences’ JS001sc Achieves Key Milestone in NSCLC Treatment
2M ago
Shanghai Junshi Biosciences Announces 2025 Q3 Results Briefing
PremiumCompany AnnouncementsShanghai Junshi Biosciences Announces 2025 Q3 Results Briefing
3M ago
Shanghai Junshi Biosciences Gains FDA Approval for JS207 Clinical Study in NSCLC
Premium
Company Announcements
Shanghai Junshi Biosciences Gains FDA Approval for JS207 Clinical Study in NSCLC
4M ago
Shanghai Junshi Biosciences to Review Nine-Month Financial Results
Premium
Company Announcements
Shanghai Junshi Biosciences to Review Nine-Month Financial Results
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100